Cognitive Remediation and Functional Skills Training in Schizophrenia

Schizophrenia Clinical Trial

Official title:

Specificity and Generalizability of Cognitive Remediation and Functional Skills Training in Schizophrenia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01175642
• Other study ID #: PSYC-085-08
• Status: Completed
• Phase: Phase 0
• First received: August 3, 2010
• Last updated: November 16, 2016
• Start date: July 2007
• Est. completion date: September 2010

Study information

• Verified date: August 2010
• Source: National Alliance for Research on Schizophrenia and Depression
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

This randomized trial is examining whether a treatment called cognitive remediation is more effective when it is paired with a social and functional skills training component.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: September 2010
• Est. primary completion date: August 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Diagnosis of schizophrenia or schizoaffective disorder

• Enrolled in outpatient mental health care

• Reading level of 6th grade or higher

• English speaking

Exclusion Criteria:

• Medical conditions known to affect cognition

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Psychotic Disorders
• Schizoaffective Disorder
• Schizophrenia

Intervention

Behavioral:
• Cognitive Remediation
Computer-based, therapist-lead cognitive remediation
• FAST
Functional adaptive skills training. Group treatment to foster the acquisition of social and adaptive skills

Locations

Country	Name	City	State
Canada	Queen's University	Kingston	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
National Alliance for Research on Schizophrenia and Depression

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	neurocognition		12 weeks	No
Secondary	functional competence	performance-based measures of functional and social competence	12 weeks	No
Secondary	neurocognition		24 weeks	No
Secondary	neurocognition		36 weeks	No
Secondary	functional competence		24 weeks	No
Secondary	functional competence		36 weeks	No